In addition, the theory of Dodd 6 and Chou FY, et al. 7 demonstrated the advantages of educating patients regarding chemotherapy's side effects and symptom management strategies that had a great impact on improving patient's quality of life.
Material and Methods
This was a multi-center, prospective study. Patients who fulfilled inclusion criteria were enrolled in the study as follows: 1) patients aged 18 years or above with solid cancer who received the first chemotherapy and were admitted to either Wattananosoth Hospital, Samitivej Sukhumvit Hospital, Phyathai2 Hospital, Samitivej Sriracha Hospital, or Chonburi Hospital between August 23 rd , 2011 and October 1 st , 2013, 2) patients who were fully conscious, 3) patients with understandable verbal communication, 4) patients who are literate in either Thai or English, and 5) patients who gave informed consent. Patients with solid cancer who required adjunctive radiation therapy were excluded. The study was approved by the ethical committee of each participating institution of study. Details of the side effects of chemotherapy and symptom self-management were imparted by a nurse.
Data collecting included the following
Demographic data e.g. sex, age, race, marital status, level of education, method of treatment before receiving chemotherapy, disease development, patient's condition and likelihood of future complications, having a caregiver, basic medication and background information was gathered. Educational levels were categorized as primary school or lower, secondary school, high school/vocational, and university or higher.
Assessment of the level of side effect severity from chemotherapy used the therapy-related symptom checklist (TRSC) form comprising 25-item symptom checklists which classified problems and the level of problem severity into five levels: level 0 = no symptom, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe.
Assessment of symptom management used the selfcare method (SCM) comprising identifiable symptoms, self care method and symptom alleviation. 8 Five levels of symptoms were classified: 0 = no symptom, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. Symptom management strategies were categorized into 1) by changing nutrition and lifestyle choices, 2) by adapting mental and physical behavior, 3) by biological therapy, 4) by herb therapy, 5) by using suggested medication, 6) by doing nothing and hoping circumstances will get better, and 7) by engaging in general activities.
TRSC and SCM were measured by the patients themselves on day 1 and day 3 after receiving chemotherapy and on the last day of each cycle until the first three cycles of treatment were completed.
Statistics analysis
Descriptive data were presented as absolute numbers, percentages for demographic parameters. Data from TRSC and SCM of each cycle were collected in OMERET program and Cronbach alpha at value of 0.70 was applied for accuracy of measurement. 8 One-way analysis of variance (one-way ANOVA) was used. Multivariate analysis using logistic regression analysis was performed to identify the independent factors that influenced patients in applying symptom management strategies during chemotherapy treatment. All statistical analyses were performed using SPSS for Windows, version 10.0 (Statistical Package for Social Science).
Results
A total of 149 patients who met the inclusion criteria were enrolled. There were 121 female (81.2%) and 28 male (18.80%) with an average age of 52.48 years. The educational level of the majority of patients who took part was university-level or higher (45.65%). Diagnoses of solid cancer consisted of breast cancer (57.72%), lung cancer (12.08%), gynecologic cancer (11.41%), colorectal cancer (11.41%), head and neck cancer (3.36%), gastric cancer (2.01%), and others (2.01%) respectively. Staging of cancer showed stage 1 (4.70%), stage 2 (46.98%), stage 3 (30.87%), stage 4 (17.45%). Most patients (94.63%) had a caregiver. Out of all enrolled patients, 73.15% were able to access knowledge about the disease (Table 1 ). There were 25 adverse symptoms that frequently developed on day 1 of receiving chemotherapy in each cycle such as hair loss (81.21%), taste change (79.19%), skin change (75.17%), loss of appetite (74.50%), and difficulty sleeping (73.15%), shown in Table 2 . The level of side effect severity, measured on day 1, day 3 after receiving chemotherapy and on the last day of each cycle until the first three cycles of treatment were completed, were averaged and are shown in Figure 1 . Based on the patients' perceptions, each side effect was ranged in the mild degree except hair loss that was graded in moderate severity. There were no severe or very severe symptoms reported.
Symptom Management Strategies of Patients with Solid Cancer during Receiving Naïve Chemotherapy
The Bangkok Medical Journal Vol. 9; February 2015 ISSN 2287-0237 (online)/ 2287-9674 (print) Phongnopakoon P et al. Table 3 shows the symptom management strategy applied by 149 enrolled patients during the first three cycles of treatment: using suggested medication (27.15%), changing nutrition and lifestyle choices (26.62%) (e.g. refraining from eating meat), doing nothing and hoping circumstances will get better (16.01%), adapting mental and physical behavior such as practicing meditation and praying at temple (15.05%), engaging in general activities such as craftsmanship and reading books (8.08%), using biological therapy such as massage with or without hot press, sipping water, and exercise (6.34%), using herb therapy (0.76%). General individual factors that influenced patient in applying symptom management strategies during chemotherapy treatment included: level of education and having access to data resources about side effect management (Table 4) . 
Discussion
According to the theory of Dodd M, et al 6 on the apparent advantages of symptom management strategy during chemotherapy treatment in patients with solid cancer, we provided this knowledge and evaluated how our patients have handled symptoms caused by chemotherapy's side effects. Results demonstrated significantly low level symptom severity after patients used self-symptom management strategies particularly in using suggested medication. This finding was comparable to the study of Piumjariyakul U. 8 Our study populations have various ways to take care of themselves. Nurses are encouraged to provide information regarding possible side effects that might occur during treatment with chemotherapy, and are encouraged to advise patients regarding symptom management strategies in order to support their self-care when experiencing unfavorable symptoms caused by chemotherapy. We highlight that patients with solid cancer can benefit from multiple advantages after using symptom management strategies as this can result in optimizing their quality of life by being able to take care of themselves and to better manage the side effects of treatment.
Conclusion
Side effects of chemotherapy commonly develop during treatment of solid cancer. Educating and providing patients the information regarding symptoms linked to chemotherapy as well as self-care management when experiencing these symptoms is crucial. A symptom management strategy is not only there to ameliorate a patient's affliction but also to optimize their quality of life during the period of chemotherapy course.
